Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro

L. Schröterová, A. Ježková, E. Rudolf, K. Caltová, V. Králová, V. Hanušová,

. 2018 ; 53 (4) : 1625-1632. [pub] 20180719

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19000503

Inositol hexaphosphate (IP6), also known as phytic acid, has been shown to exhibit anticancer effects in a number of preclinical tumor models. IP6 decreases proliferation by arresting cells in the G0/G1 phase, inhibits iron-mediated oxidative reactions, enhances differentiation and stimulates apoptosis. The present study attempted to characterize the effect of IP6 on the migration and adhesion of colon cancer SW620 cells. IP6 was assessed at concentrations of 0.2 and 1 mM during 12, 24 and 48 h of exposure. Migration ability was measured with the real-time xCELLigence Real-Time Cell Analyzer Dual Purpose system. The expression of mRNA and proteins involved in migration and cancer progression [epithelial cell adhesion molecule, intercellular adhesion molecule-1, β-catenin, N-cadherin, E-cadherin, matrix metalloproteinase (MMP)-2 and MMP-9] was determined by reverse transcription-quantitative polymerase chain reaction and western blot analysis. The changes in the expression and subcellular localization of E-cadherin were determined by indirect immunofluorescence. IP6 induced a decrease in the migration ability of the tested SW620 cell line. IP6-treated cells also showed decreased expression of N-cadherin, increased levels of E-cadherin and decreased expression of MMP-2 and MMP-9. These results indicated that IP6 has potential to modulate the migration ability and expression of markers associated with invasion in SW620 cells; however, further analysis is necessary to obtain a detailed understanding of the mechanism of action.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000503
003      
CZ-PrNML
005      
20190121103836.0
007      
ta
008      
190107s2018 gr f 000 0|eng||
009      
AR
024    7_
$a 10.3892/ijo.2018.4488 $2 doi
035    __
$a (PubMed)30066850
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Schröterová, Ladislava $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
245    10
$a Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro / $c L. Schröterová, A. Ježková, E. Rudolf, K. Caltová, V. Králová, V. Hanušová,
520    9_
$a Inositol hexaphosphate (IP6), also known as phytic acid, has been shown to exhibit anticancer effects in a number of preclinical tumor models. IP6 decreases proliferation by arresting cells in the G0/G1 phase, inhibits iron-mediated oxidative reactions, enhances differentiation and stimulates apoptosis. The present study attempted to characterize the effect of IP6 on the migration and adhesion of colon cancer SW620 cells. IP6 was assessed at concentrations of 0.2 and 1 mM during 12, 24 and 48 h of exposure. Migration ability was measured with the real-time xCELLigence Real-Time Cell Analyzer Dual Purpose system. The expression of mRNA and proteins involved in migration and cancer progression [epithelial cell adhesion molecule, intercellular adhesion molecule-1, β-catenin, N-cadherin, E-cadherin, matrix metalloproteinase (MMP)-2 and MMP-9] was determined by reverse transcription-quantitative polymerase chain reaction and western blot analysis. The changes in the expression and subcellular localization of E-cadherin were determined by indirect immunofluorescence. IP6 induced a decrease in the migration ability of the tested SW620 cell line. IP6-treated cells also showed decreased expression of N-cadherin, increased levels of E-cadherin and decreased expression of MMP-2 and MMP-9. These results indicated that IP6 has potential to modulate the migration ability and expression of markers associated with invasion in SW620 cells; however, further analysis is necessary to obtain a detailed understanding of the mechanism of action.
650    _2
$a protinádorové látky $x farmakologie $x terapeutické užití $7 D000970
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a buněčná adheze $x účinky léků $7 D002448
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a pohyb buněk $x účinky léků $7 D002465
650    _2
$a kolorektální nádory $x farmakoterapie $x patologie $7 D015179
650    _2
$a progrese nemoci $7 D018450
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a lidé $7 D006801
650    _2
$a invazivní růst nádoru $x prevence a kontrola $7 D009361
650    _2
$a kyselina fytová $x farmakologie $x terapeutické užití $7 D010833
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ježková, Alena $u Department of Biochemical Sciences, Charles University, Faculty of Pharmacy, 500 05 Hradec Králové, Czech Republic.
700    1_
$a Rudolf, Emil $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
700    1_
$a Caltová, Kateřina $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
700    1_
$a Králová, Věra $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
700    1_
$a Hanušová, Veronika $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
773    0_
$w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 53, č. 4 (2018), s. 1625-1632
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30066850 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190121104055 $b ABA008
999    __
$a ok $b bmc $g 1364572 $s 1038626
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 53 $c 4 $d 1625-1632 $e 20180719 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...